Thalidomide treatment attenuates chemotherapy-induced gonadal toxicity

Fertility and Sterility

Volumn 95, Issue 2, 2011, Pages 819-822

  Ochalski, Melanie E ^a   Shuttleworth, Jennifer J ^a   Chu, Tianjiao ^a   Orwig, Kyle E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

alkylating chemotherapy; busulfan; chemotherapy induced gonadal failure; fertility; gonadal protection; ovarian follicles; Thalidomide

Indexed keywords

BUSULFAN; THALIDOMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESTRUS CYCLE; FEMALE; GONAD; MOUSE; NONHUMAN; OVARIAN RESERVE; OVARY FOLLICLE; OVARY FUNCTION; OVARY INSUFFICIENCY; PRIORITY JOURNAL; VAGINA SMEAR;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL COUNT; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; FEMALE; GONADS; MICE; MICE, INBRED C57BL; OVARY; PRIMARY OVARIAN INSUFFICIENCY; THALIDOMIDE;

EID: 78751567882     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.09.020     Document Type: Article

References (16)

1. Horner MJ RL, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, et al, eds. SEER cancer statistics review, 1975-2006. Bethesda, MD: National Cancer Institute. June 2010.
2. A. Badawy, A. Elnashar, M. El-Ashry, and M. Shahat Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study Fertil Steril 91 2009 694 697
3. K. Oktay, M. Sonmezer, O. Oktem, K. Fox, G. Emons, and H. Bang Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury Oncologist 12 2007 1055 1066
4. S.K. Teo Properties of thalidomide and its analogues: implications for anticancer therapy AAPS J 7 2005 E14 E19
5. S.P. Dharia, M.P. Steinkampf, and C. Cater Thalidomide-induced amenorrhea: case report and literature review Fertil Steril 82 2004 460 462
6. W.M. Generoso, S.K. Stout, and S.W. Huff Effects of alkylating chemicals on reproductive capacity of adult female mice Mutat Res 13 1971 172 184
7. Fekete E. Resources. In: Biology of the laboratory mouse, Snell GD, ed. New York: Dover Publications, 1941:89-167.
8. E. Allen The oestrus cycle in the mouse Am J Anat 30 1922 297 371
9. T. Pedersen, and H. Peters Proposal for a classification of oocytes and follicles in the mouse ovary J Reprod Fertil 17 1968 555 557
10. J.S. Charleston, K.R. Hansen, A.C. Thyer, L.B. Charleston, A. Gougeon, and J.R. Siebert Estimating human ovarian nongrowing follicle number: the application of modern stereology techniques to an old problem Hum Reprod 22 2007 2103 2110
11. B. Bolon, T.J. Bucci, A.R. Warbritton, J.J. Chen, D.R. Mattison, and J.J. Heindel Differential follicle counts as a screen for chemically induced ovarian toxicity in mice: results from continuous breeding bioassays Fundam Appl Toxicol 39 1997 1 10
12. Gougeon A, Delangle A, Arouche N, Stridsberg M, Gotteland JP, Loumaye E. Kit ligand and the somatostatin receptor antagonist, BIM-23627, stimulate in vitro resting follicle growth in the neonatal mouse ovary. Endocrinology;151: 1299-1309.
13. M. Myers, K.L. Britt, N.G. Wreford, F.J. Ebling, and J.B. Kerr Methods for quantifying follicular numbers within the mouse ovary Reproduction 127 2004 569 580
14. J.F.L. Nelson, P. Randall, C. Sims, and C. Finch A longitudinal study of estrous cyclicity in aging C57/BL mice: cycle frequency, length and cytology Biol Reprod 27 1982 327 339
15. D.R. Mattison, M.S. Nightingale, and K. Shiromizu Effects of toxic substances on female reproduction Environ Health Perspect 48 1983 43 52
16. S.K. Teo, D.I. Stirling, and J.B. Zeldis Thalidomide as a novel therapeutic agent: new uses for an old product Drug Discov Today 10 2005 107 114